Crossmark

Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities

Published Online: 2017-04-04

Published Print: 2017-12

Authors

Micevic, Goran https://orcid.org/0000-0003-0329-1053
Theodosakis, Nicholas

Bosenberg, Marcus
Funding

Funding for this research was provided by:

National Institutes of Health (T32GM007205)

National Cancer Institute (F30CA196089)
License Information

Text and Data Mining valid from 2017-04-04

Version of Record valid from 2017-04-04
More Information

Article History

Received: 16 December 2016

Accepted: 24 March 2017

First Online: 4 April 2017

Document is current